SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.25-2.7%Jan 28 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (16157)3/1/1998 5:22:00 PM
From: CYBERKEN  Read Replies (3) of 32384
 
Many investors in the technology fields buy the best science or technology available and just wait for the market to recognize it. Most people who invest that way have done extremely well over the last 10 to 20 years. I am unable to invest without putting as great a weight on the quality of management, and have abandoned stocks with great science when the mgt seemed to be faltering. Never underestimate the ability of a bad management team to destroy good prospects for any company.

Ligand is one of those companies that you could invest in just for the pipeline and their chosen technologies. But since the Panretin trials they have proven to me what I suspected when I first bought in: That the management team is focused, talented, and able to bring their products through the FDA process in minimum time and with maximum effect. There are very few companies in biotech who have achieved this level of management competance (and I'm looking to invest in all of them). This will make a big difference as biotech goes forward, as perhaps the majority of current companies will fall out.

Ligand is purely and simply a long-term buy-and-hold, with the next tier coming soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext